Date published: 2025-11-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

U-54494A hydrochloride (CAS 112465-94-8)

0.0(0)
Write a reviewAsk a question

Application:
U-54494A hydrochloride is a benzamide NMDA antagonist
CAS Number:
112465-94-8
Molecular Weight:
391.8
Molecular Formula:
C18H24Cl2N2O•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

U-54494A hydrochloride is a KOR (κ-opioid receptor) agonist. This compound also has potential uses as an NMDA antagonist.


U-54494A hydrochloride (CAS 112465-94-8) References

  1. NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice.  |  De Sarro, G., et al. 2000. Eur J Pharmacol. 408: 25-34. PMID: 11070180
  2. Possible mechanism involved in the anticonvulsant action of butorphanol in mice.  |  Manocha, A., et al. 2003. Pharmacol Biochem Behav. 74: 343-50. PMID: 12479953
  3. Modulation of release of acetylcholine from the striatum by a proposed excitatory amino acid antagonist U-54494A: comparison with known antagonists, diazepam and phenytoin.  |  Sethy, VH. and Sage, GP. 1992. Neuropharmacology. 31: 111-4. PMID: 1348110
  4. Studies on the anticonvulsant effect of U50488H on maximal electroshock seizure in mice.  |  Manocha, A., et al. 2003. Pharmacol Biochem Behav. 76: 111-7. PMID: 13679223
  5. The kappa opioid agonist U50,488 potentiates 6-hydroxydopamine-induced neurotoxicity on dopaminergic neurons.  |  Marin, C., et al. 2005. Exp Neurol. 191: 41-52. PMID: 15589511
  6. In vitro depressant effects of U-54494A, an anticonvulsant related to kappa opioids, in the hippocampus.  |  Proietti, ML., et al. 1991. Neuropharmacology. 30: 637-42. PMID: 1656303
  7. The kappa opioid-related anticonvulsants U-50488H and U-54494A attenuate N-methyl-D-aspartate induced brain injury in the neonatal rat.  |  Hudson, CJ., et al. 1991. Brain Res. 564: 261-7. PMID: 1725768
  8. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.  |  Mei, F., et al. 2016. J Neurosci. 36: 7925-35. PMID: 27466337
  9. A Cellular Assay for the Identification and Characterization of Connexin Gap Junction Modulators.  |  Danish, A., et al. 2021. Int J Mol Sci. 22: PMID: 33572565
  10. Dual inhibitory action of enadoline (CI977) on release of amino acids in the rat hippocampus.  |  Millan, MH., et al. 1995. Eur J Pharmacol. 279: 75-81. PMID: 7556386
  11. Kappa opioid receptor agonists inhibit the pilocarpine-induced seizures and toxicity in the mouse.  |  Przewłocka, B., et al. 1994. Eur Neuropsychopharmacol. 4: 527-33. PMID: 7894264
  12. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?  |  Löscher, W. and Schmidt, D. 1994. Epilepsy Res. 17: 95-134. PMID: 8194514
  13. Metaphit-induced audiogenic seizures in mice: I. Pharmacologic characterization.  |  Debler, EA., et al. 1993. Epilepsia. 34: 201-10. PMID: 8384106
  14. Two metabolites of anticonvulsant U-54494A: their anticonvulsant activity and interaction with sodium channel.  |  Zhu, Y., et al. 1993. Brain Res. 606: 50-5. PMID: 8384924
  15. Developmental and regional alteration of kappa-opioid receptors in seizure-susceptible EL mouse brain.  |  Kai, T., et al. 1998. Neurochem Res. 23: 163-8. PMID: 9475510

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

U-54494A hydrochloride, 10 mg

sc-200479
10 mg
$135.00

U-54494A hydrochloride, 50 mg

sc-200479A
50 mg
$595.00